Format

Send to

Choose Destination
See comment in PubMed Commons below
J Inherit Metab Dis. 2004;27(6):791-3.

Raised HDL cholesterol in Fabry disease: response to enzyme replacement therapy.

Author information

1
Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK.

Abstract

Fabry disease patients have increased risk of vascular disease despite cardioprotective increased HDL-cholesterol. Enzyme therapy does not significantly alter the lipid profile in the short term.

PMID:
15617195
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center